Hepatitis C virus core protein inhibits human immunodeficiency virus type 1 replication

Area of Science:

• Virology
• Molecular Biology
• Immunology

Background:

• Hepatitis C virus (HCV) core protein previously shown to repress human immunodeficiency virus type 1 (HIV-1) transcription.
• Understanding the precise mechanism and implications of this interaction is crucial for co-infection research.

Purpose of the Study:

• To pinpoint the specific region of HIV-1 LTR targeted by HCV core protein for transcriptional repression.
• To investigate the role of HIV-1 Tat protein in abrogating this repression.
• To evaluate the impact of HCV core protein expression on HIV-1 replication in various cell models.

Main Methods:

• Localization of the HCV core protein-response domain within the HIV-1 LTR using deletion analysis.
• Assessing HIV-1 LTR basal transcription activity in cells expressing HCV core protein.
• Evaluating HIV-1 replication in cell lines with and without HCV core protein expression.

Main Results:

• The HCV core protein-response domain was mapped to nucleotides -65 to +3 of the HIV-1 LTR, excluding known regulatory elements.
• HCV core protein-mediated repression of HIV-1 LTR was reversed by the HIV-1 Tat protein.
• Expression of HCV core protein inhibited HIV-1 replication in HeLa-T4 cells and in CD4+ and CD4-lymphocytic cell lines.

Conclusions:

• HCV core protein represses basal HIV-1 transcription via a specific LTR domain independent of known transcription factor binding sites.
• This repression mechanism, acting before Tat accumulation, effectively restricts HIV-1 transcription and modulates viral replication.
• HCV core protein represents a potential factor influencing the course of HIV-1 infection in co-infected individuals.